Zydus Wellness Ltd

Promoter share transmission under PIT

• Code: Code of Conduct for Insider Trading under SEBI PIT Regulations, Regulation 7(2).
• Event: Transmission of 27,250 equity shares to promoter group member Prashant Babubhai Patel.
• Intimation: Disclosure dated Aug 21, 2026; acquisition date Aug 19, 2026; off-market.
• Holder details: Recipient is Prashant Babubhai Patel; Category: Promoter Group.
• Post-change: 27,250 shares held; percentage shown as 0.00%.

Rating action and instrument

• Rating: CARE AA+; Stable for ZWPL's long-term bank facilities.
• Facility amount: ₹12 crore.
• Instrument: Long-term bank facilities.

Agency and date

• Agency: CARE Ratings Limited (CareEdge Ratings).
• Rating communication date: August 18, 2026.

Rationale and drivers

• Established FMCG brands and broad distribution underpin resilience.
• Strong parent support from Zydus Lifesciences; expected backing.
• Diversified product portfolio across food, personal care, and VMS.
• Acquisition-driven growth: Comfort Click expanded revenue base.
• Risks: seasonality, raw materials volatility, competition.
• Debt-funded acquisitions raised leverage; bullet repayment due FY29.
• Liquidity and coverage remain comfortable; PBILDT margin near 5x interest.

Credit profile metrics

• Gearing 0.55x; net worth ₹5,826 crore (FY26).
• PBILDT margin ~12.8% (FY26); management targets 17–18%.
• Interest coverage ~5.2x.
• Total debt ₹3,203 crore as of 3/31/2026; gearing headroom noted.

Liquidity

• Liquidity: ₹115 crore cash and liquid investments.
• Near-term repayments ~₹2 crore annually in FY27–28.
• Working capital utilization ~36%.
• ZLL parent support expected in exigencies.

Outlook and validity

• Outlook: Stable.
• Rating validity: about one year from initial communication.

Meeting Details

• Date and time: August 4, 2026 at 3:00 p.m. IST
• Type and mode: Group earnings conference call, virtual
• Event: Q1 FY27 Earnings Conference Call; organiser: Zydus Wellness (ICICI Securities co-host)
• Recording: Conference was recorded; transcript attached

Participants

• CEO: Tarun Arora
• Non-Executive Director: Ganesh Nayak
• CFO: Umesh Parikh

Purpose

• Purpose: Discuss Q1 FY27 earnings results
• Format: Investor Q&A following management remarks

Meeting Details

• Aug 4, 2026 at 3:00 p.m. IST
• Q1 FY27 earnings conference call; group virtual
• Organizer: ICICI Securities (co-host) for Zydus Wellness Q1 FY27 call
• Key company participants: CEO, CFO, Non-Executive Director
• Purpose: discuss quarterly results and investor Q&A
• Recording available; transcript attached

Meeting Details

• Date: Friday, August 14, 2026.
• Type: Group and one-on-one meeting; Mode: physical in Mumbai.
• Conference: Equirus Annual India Conference 2026; Hosted by Equirus Securities.

Participants

• Company representatives will participate; Role: Company Secretary & Compliance Officer.

Purpose

• Purpose: Analyst/Institutional Investors’ Conference.

Meeting Details

• Date: August 4, 2026; time and venue not disclosed.

Key Agenda Items

• Approval of unaudited financial results for the quarter ended June 30, 2026.

Other Notes

• Trading window closed until August 6, 2026; opens August 7, 2026.

Penalty against UK subsidiary

• CCL is a step-down wholly owned UK subsidiary.
• Polish Tax Administration Chamber in Szczecin imposed PLN 54,000 penalty.
• Order dated July 10, 2026, at 5:56 p.m.
• Penalty amount approx ₹1.35 million based on Bloomberg rate on July 10, 2026.
• No material impact beyond payment of the penalty.